Rubicon Organics Future Growth
Future criteria checks 1/6
Rubicon Organics is forecast to grow earnings and revenue by 66.2% and 9.3% per annum respectively while EPS is expected to grow by 53.7% per annum.
Key information
66.2%
Earnings growth rate
53.7%
EPS growth rate
| Pharmaceuticals earnings growth | 66.0% |
| Revenue growth rate | 9.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 05 Apr 2024 |
Recent future growth updates
Recent updates
Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)
May 06
Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
Mar 07Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
Sep 28Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet
Jun 13Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?
Jun 06Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?
Jan 09Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt
Sep 19What Type Of Shareholders Own The Most Number of Rubicon Organics Inc. (CSE:ROMJ) Shares?
Jul 29
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 48 | 0 | N/A | 6 | 1 |
| 12/31/2024 | 45 | -1 | N/A | 4 | 1 |
| 12/31/2023 | 40 | -2 | 2 | 5 | N/A |
| 9/30/2023 | 41 | -5 | 3 | 7 | N/A |
| 6/30/2023 | 42 | -2 | 3 | 7 | N/A |
| 3/31/2023 | 39 | -3 | 0 | 4 | N/A |
| 12/31/2022 | 36 | -4 | -2 | 2 | N/A |
| 9/30/2022 | 31 | -2 | -4 | 0 | N/A |
| 6/30/2022 | 28 | -8 | -7 | -3 | N/A |
| 3/31/2022 | 24 | -12 | -10 | -6 | N/A |
| 12/31/2021 | 23 | -15 | -16 | -10 | N/A |
| 9/30/2021 | 21 | -18 | -20 | -14 | N/A |
| 6/30/2021 | 17 | -18 | -22 | -17 | N/A |
| 3/31/2021 | 13 | -15 | -23 | -17 | N/A |
| 12/31/2020 | 9 | -14 | -20 | -14 | N/A |
| 9/30/2020 | 5 | -12 | -21 | -14 | N/A |
| 6/30/2020 | 1 | -11 | -22 | -13 | N/A |
| 3/31/2020 | 0 | -12 | -21 | -12 | N/A |
| 12/31/2019 | N/A | -11 | -18 | -10 | N/A |
| 9/30/2019 | -1 | -9 | -16 | -11 | N/A |
| 6/30/2019 | -1 | -10 | -19 | -11 | N/A |
| 3/31/2019 | 0 | -25 | -16 | -7 | N/A |
| 12/31/2018 | N/A | -25 | -18 | -9 | N/A |
| 9/30/2018 | 2 | -26 | -19 | -10 | N/A |
| 6/30/2018 | 1 | -23 | -11 | -5 | N/A |
| 3/31/2018 | 1 | -8 | -13 | -7 | N/A |
| 12/31/2017 | 1 | -6 | -9 | -4 | N/A |
| 12/31/2016 | 2 | 2 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ROMJ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ROMJ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ROMJ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ROMJ's revenue (9.3% per year) is forecast to grow faster than the Canadian market (6.6% per year).
High Growth Revenue: ROMJ's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ROMJ's Return on Equity is forecast to be high in 3 years time